Press Release

Emerald’s CEO, Adi Zamir, was chosen to take part in the first women entrepreneur delegation to the silicon valley.

adi-zamir

Emerald Medical Applications Enters Joint Sponsorship Agreement with the Hispanic Professionals Association Inc. NY

Emerald Medical Applications Corp. (MRLA) (“Emerald” or the “Company”), the Israeli-based company engaged in the development and sale of DermaCompare™, its proprietary artificial intelligence technology for the early diagnosis of melanoma and other skin cancers, today announced that it has signed a term sheet with the Hispanic Professionals Association Inc. New York (“AHPSI”) to sponsor the marketing of the Dermacompare technology to its physician and nurse members.

Read more: http://finance.yahoo.com/news/emerald-medical-applications-enters-joint-124300826.html

eSanté+Big Data : Emerald (Israël) 1er Prix Publicis à Vivatech Paris

 

Lors du salon VIVA Technology, le premier prix Publicis a été décerné à la société israélienne
EMERALD, représentée par Lior Wayn, apportant une innovation dans le diagnostic des
cancers de la peau. Le classement SHENZEN classe cette société comme 3ème start-up
importante au monde.

http://www.israelvalley.com/news/2016/07/17/50570/esant-big-data-emerald-isra-l-1er-prix-publicis-vivatech-paris

Département des Affaires Commerciales de l’Ambassade d’Israël

Paris, France

Plus de cinquante sociétés israéliennes ainsi que 15 intervenants ont présenté la future génération de technologies innovantes lors de la première édition de cet évènement rassemblant des acteurs mondiaux du digital « Viva Technology : Start-up connect ». L’évènement, organisé par Publicis et les Echos, a ressemblé du 30 juin au 2 juillet 2016 les plus grands groupes internationaux et des startups du monde entière autour de l’ensemble des thématiques de l’innovation.

Israël à « Viva Technology » : l’aperçu d’un succès incontournable

From AI to the Internet of Things: Publicis picks 90 startups for mentoring and funding

At the Viva Technology conference, held in Paris, France, June 30 to July 2, 2016, Publicis Groupe announced its pick of the 90 most innovative startups that will receive funding and mentoring as part of the Publicis90 global initiative. The 90 winning projects reflect the major current trends in technology, including virtual reality, the Internet of Things and data security.
The top three winning projects include Israeli startup Emerald Medical Applications, which specializes in dermatology, using the latest image recognition technology to make skin cancer detection quicker and easier.

http://finance.yahoo.com/news/ai-internet-things-publicis-picks-90-startups-mentoring-132327284.html

PUBLICIS90: Publicis Groupe is Financing 90 Startups at #VIVATECH

On the occasion of its 90th anniversary, Publicis Groupe (Paris:PUB) has launched #Publicis90, a global initiative to provide funding and mentoring for a selection of 90 of the most innovative startups or scale-ups. The call for entries, which was launched in January 2016, was a tribute to the entrepreneurial spirit of Publicis founder Marcel Bleustein-Blanchet. Over 3,500 applications were received from more than 130 countries by entrepreneurs, students and by Publicis Groupe employees.

http://www.businesswire.com/news/home/20160701005747/en/PUBLICIS90-Publicis-Groupe-Financing-90-Startups-VIVATECH

Bots, IoT and cancer research among projects chosen for Publicis90 initiative

The three biggest winners were: Emerald Medical Applications, which uses image recognition technology for quicker detection of skin cancer; Recat.Ai, a startup founded by graduates of the French coding school 42 that helps developers creating messaging bots; and Wiseye, an Israeli company looking to bring the Internet of Things to retail.

http://www.campaignlive.com/article/bots-iot-cancer-research-among-projects-chosen-publicis90-initiative/1401044

TEDx Berlin

DKV Hamburg

WallSTConference 03 23 2015 Emerald Medical Applications

Axel Springer accelerator

Mark Zuckerberg (Facebook)

Signals Wide Use Of Artificial Intelligence On Internet For Medical Uses – (Forbes  APR 30, 2016)